Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Health habits’ connection to dementia in the spotlight as new year begins
By
Lois A. Bowers
Jan 04, 2022
An update to the National Plan to Address Alzheimer’s Disease, as well as news of potential treatments and a finding that “astonished” researchers add up to promising news to start the new...
McKnight’s Senior Living Newsmakers Podcast with Jill Ricker
Nov 08, 2021
Jill Ricker, director of operations for SAIDO Learning at Covenant Living, explains to McKnight’s Senior Living Editor Lois Bowers the SAIDO program for people living with dementia — what it is...
More news for Friday, July 9
Jul 09, 2021
Monday is deadline to comment on whether vaccine reporting rule should apply to assisted living … Biden order to curtail licensure requirements, noncompete agreements: report … Nine states...
COVID-19 falls from America’s No. 1 killer to No. 7 by June
Jul 01, 2021
COVID-19 deaths have fallen sharply as vaccination rates have surged in recent months.
More news for Monday, June 28
Jun 28, 2021
DA reverses plans to seek death penalty for alleged senior living serial killer … FDA grants breakthrough therapy designation to donanemab and lecanemab for Alzheimer’s … Vapors from alcohol-based...
The question you need to add to care planning and interdisciplinary team meetings
By
Julia Larimer
Apr 29, 2021
So often, we apply root cause analysis to determine the reason for a resident’s fall or change in behavior. Could Jane have a UTI? Did Roger have his walker with him when he fell? How did the staff approach...
Creating an innovative yet practical approach to memory care
By
Jennifer Ingerson
Mar 08, 2021
Loretto has focused on memory care for decades, and over the past five years, we embarked on one of the biggest undertakings of our history to create an innovative and yet practical solution to a major...
Omnibus bill includes $3.1 billion for dementia research
By
Lois A. Bowers
Dec 22, 2020
The $1.4 trillion appropriations omnibus spending bill advanced by congressional leaders on Monday includes an increase of more than $300 million in funding for dementia research at the National Institutes...
91 groups, individuals praise bipartisan Alzheimer’s-related efforts in Senate
By
Lois A. Bowers
Dec 14, 2020
Twenty-seven organizations and 64 individuals told Sens. Pat Toomey (R-PA) and Debbie Stabenow (D-MI) that they are “particularly encouraged” by the lawmakers’ recommendation that the Center for...